Advanced BioScience Laboratories, Inc.
Advanced BioScience Laboratories, Inc. (ABL) is a global biomedical contract research and manufacturing organization dedicated to advancing vaccines, therapeutics, and other biologic products. ABL leverages its expertise in product development, GMP manufacturing, and immunological testing to support the development of candidate vaccines and therapeutics through preclinical and clinical stages. The company is involved in producing and testing oncolytic viruses, gene therapies, immunotherapies, viral vaccines, and recombinant protein vaccines.
Advanced BioScience Laboratories, Inc.
9800 Medical Center Drive, Building D, Rockville, MD 20850 USA
What We Do
ABL provides a range of ELISA kits for various applications in research and diagnostics.
ABL offers comprehensive biomanufacturing services including virus manufacturing, process development, aseptic fill finish, cell & virus banking, and biologics and QC testing.
ABL partners with government entities to advance research and development in the field of biomanufacturing and therapeutics.
Application Area
Regenerative Medicine
Vaccines
Show LessDigital Health Technologies
News & Updates
ABL's U.S. location is accredited for Good Clinical Laboratory Practices (GCLP) standards.
ABL Lyon's site is accredited for ISO 9001.
ABL's U.S. location is accredited for ISO 9001.
ABL Europe's Strasbourg site received a Certificate of GMP Compliance for Human Investigational Medicinal Products: Aseptic Filling, Gene Therapy Product Manufacturing, and Secondary Packaging.
ABL Europe's Strasbourg site received a Certificate of GMP Compliance for Quality Control Testing.
ABL Lyon attended the 13th Congress of ECCO in Vienna, Austria, from February 14-17, 2018.
ABL attended the 17th Annual World Vaccine Congress in Washington, D.C., from April 10-12, 2017.
ABL participated in the BIO International Convention in Chicago, IL, from April 22-25, 2013, where Dr. James Richardson presented on overcoming roadblocks in vaccine development.
ABL scientists attended the Keystone Symposia on HIV Vaccines in Keystone, Colorado, from February 10-15, 2013.
ABL attended the AAPS PharmSci 360 Annual Meeting in Washington, D.C., from November 4-7, 2018.
Maria Ferrari presented a poster at the 2019 Keystone Symposia Conference: HIV Vaccines (X7) in Whistler, British Columbia, Canada.
ABL attended the World Vaccine Congress in Washington, D.C., from April 2-5, 2018.
ABL presented services for preclinical testing, cGMP manufacture, and immunomonitoring of biotherapeutics at the AAPS National Biotechnology Conference in San Diego, CA, from May 21-23, 2012.
ABL staff attended the MassBio Annual Meeting in Cambridge, MA, on April 3, 2014.
ABL attended the Life Science Innovation Northwest 2014 conference in Seattle, WA, from June 19-20, 2014.
ABL attended the 2017 Immuno-Oncology Summit in Boston, MA, from August 28 to September 1, 2017.
ABL attended the 9th Annual Non-Dilutive Funding Summit in San Francisco, CA, on January 15, 2014.
ABL attended the ImmunoTX Summit in San Diego, CA, from February 6-7, 2017.
ABL attended the 11th Annual PEGS Boston conference in Boston, MA, from May 4-8, 2015.
ABL attended the 15th CIMT Annual Symposium in Mainz, Germany, from May 10-11, 2017.
ABL attended the 2018 Immunogenicity & Bioassay Summit in Washington, D.C., from October 23-26, 2018.
ABL attended the 2017 BIO International Convention in San Diego, CA, from June 19-22, 2017.
ABL attended the 2018 BIO International Convention in Boston, MA, from June 4-7, 2018.
ABL attended the 2019 World Vaccine Congress in Washington, D.C., from April 14-17, 2019.
ABL attended the 2016 ASGCT Annual Meeting in Washington, DC, from May 4-6, 2016.
ABL attended the 8th Annual Immunotherapeutics and Vaccine Summit in Boston, MA, from August 13-15, 2013.
ABL attended the 16th Annual Contracting & Outsourcing Conference & Tabletop Exhibition in New Brunswick, NJ, from September 14-15, 2017.
ABL attended the IBC Biopharmaceutical Development and Production Week in San Diego, CA, from March 24-27, 2014.
ABL and Ascend Representatives will be attending the Advanced Therapies Week in Dallas, TX, from January 20-23, 2025.
Meet Erika Wachs from ABL at the Viral Vector Process Development & Manufacturing Summit in Boston, MA, from February 19-21, 2025.
Ascend Representatives will be attending the Gene Therapy Development Summit in Boston, MA, from March 25-27, 2025.
Ascend Representatives will be attending the Meeting on the Mediterranean in Rome, IT, from April 15-17, 2025.
Meet Tim Fouts, CSO and other ABL team members at the World Vaccine Congress in Washington, DC, from April 22-24, 2025.
ABL and Ascend Representatives will be attending the American Society of Gene and Cell Therapy in New Orleans, LA, from May 14-17, 2025.
ABL and Ascend Representatives will be attending the Bioprocessing Summit in Boston, MA, from August 18-22, 2025.
ABL and Ascend Representatives will be attending the Meeting on the Mesa in Phoenix, AZ, from October 6-8, 2025.
Ascend Representatives will be attending the European Society of Gene and Cell Therapy in Sevilla, SP, from October 7-10, 2025.